Holen Sie sich die Stockscreener-App
114.84
0.55%
-0.64
Handel nachbörslich:
114.84
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt A?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$115.48
Offen:
$115.14
24-Stunden-Volumen:
1.15M
Relative Volume:
0.52
Marktkapitalisierung:
$32.45B
Einnahmen:
$7.07B
Nettoeinkommen (Verlust:
$1.29B
KGV:
25.32
EPS:
4.5355
Netto-Cashflow:
$993.00M
1W Leistung:
+2.53%
1M Leistung:
-0.20%
6M Leistung:
-18.90%
1J Leistung:
+11.50%
1-Tages-Spanne:
$113.02
$115.68
1-Wochen-Bereich:
$111.89
$117.32
52-Wochen-Spanne:
$96.43
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Firmenname
Agilent Technologies Inc
Sektor
Branche
Telefon
(408) 345-8886
Adresse
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
114.84 | 32.63B | 7.07B | 1.29B | 993.00M | 4.5355 |
TMO
Thermo Fisher Scientific Inc
|
488.19 | 182.57B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
192.12 | 135.26B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
577.44 | 45.24B | 4.30B | 1.06B | 1.04B | 13.08 |
WAT
Waters Corp
|
304.09 | 29.85B | 3.17B | 642.63M | 516.49M | 10.77 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Eingeleitet | HSBC Securities | Buy |
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-12-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-10-08 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-10-08 | Hochstufung | UBS | Neutral → Buy |
| 2025-02-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-04-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-11-17 | Herabstufung | UBS | Buy → Neutral |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Bestätigt | Barclays | Equal Weight |
| 2023-05-24 | Bestätigt | BofA Securities | Buy |
| 2023-05-24 | Bestätigt | Citigroup | Neutral |
| 2023-05-24 | Bestätigt | Credit Suisse | Outperform |
| 2023-05-24 | Bestätigt | Evercore ISI | Outperform |
| 2023-05-24 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Bestätigt | Robert W. Baird | Outperform |
| 2023-05-24 | Bestätigt | SVB Securities | Outperform |
| 2023-05-24 | Bestätigt | Stifel | Hold |
| 2023-05-24 | Bestätigt | TD Cowen | Outperform |
| 2023-05-24 | Bestätigt | Wells Fargo | Overweight |
| 2023-05-11 | Eingeleitet | Barclays | Equal Weight |
| 2023-01-10 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2022-07-08 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Bestätigt | BofA Securities | Buy |
| 2022-02-23 | Bestätigt | Citigroup | Buy |
| 2022-02-23 | Bestätigt | Cowen | Outperform |
| 2022-02-23 | Bestätigt | Evercore ISI | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-23 | Bestätigt | Wells Fargo | Overweight |
| 2021-11-23 | Bestätigt | BofA Securities | Buy |
| 2021-11-23 | Bestätigt | Cowen | Outperform |
| 2021-11-23 | Bestätigt | Stifel | Hold |
| 2021-03-18 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-25 | Hochstufung | UBS | Neutral → Buy |
| 2020-11-17 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Neutral |
| 2020-08-19 | Bestätigt | BofA Securities | Neutral |
| 2020-08-19 | Bestätigt | Citigroup | Neutral |
| 2020-08-19 | Bestätigt | Jefferies | Buy |
| 2020-08-19 | Bestätigt | Robert W. Baird | Outperform |
| 2020-08-19 | Bestätigt | SVB Leerink | Outperform |
| 2020-08-19 | Bestätigt | Stifel | Hold |
| 2020-08-19 | Bestätigt | Wells Fargo | Overweight |
| 2020-02-24 | Herabstufung | Needham | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-11-26 | Bestätigt | Needham | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-10-18 | Herabstufung | UBS | Buy → Neutral |
| 2019-07-16 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Herabstufung | Barclays | Overweight → Equal Weight |
Alle ansehen
Agilent Technologies Inc Aktie (A) Neueste Nachrichten
Agilent CLO Departing With Severance After Less Than 2 Years in Role - law.com
Evercore ISI Adjusts Agilent Technologies Price Target to $140 From $160, Maintains Outperform Rating - marketscreener.com
Agilent Technologies Severance Agreement with Bret DiMarco: Key Terms, Release of Claims, and Executive Transition Details - Minichart
Agilent Technologies Adjusts Valuation Amid Strong Institutional Support and Financial Metrics - Markets Mojo
Agilent Technologies (A) to acquire Biocare Medical for $950M - MSN
Laboratory Chromatograph: Core Tool in Analytical Science - AD HOC NEWS
Agilent Technologies, Inc. (A) stock price, news, quote and history - Yahoo Finance UK
A PE Ratio & Valuation, Is A Overvalued - Intellectia AI
Agilent Technologies Announces Executive Transition Agreement with Bret DiMarco – Key Terms and SEC Filing Details 11 - minichart.com.sg
Quintet Private Bank Europe S.A. Has $1.26 Million Position in Agilent Technologies, Inc. $A - marketbeat.com
Agilent Technologies, Inc. (NYSE:A) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Has $1.70 Million Position in Agilent Technologies, Inc. $A - marketbeat.com
Agilent Technologies, Inc. $A Shares Sold by Allspring Global Investments Holdings LLC - marketbeat.com
Agilent Technologies, Inc. (A) latest stock news and headlines - Yahoo Finance Singapore
Agilent Announces Transition Plan for Chief Legal Officer - TipRanks
Agilent Technologies, Inc. (A) Stock forecasts - Yahoo Finance UK
Agilent Technologies announces transition of chief legal officer Bret DiMarco By Investing.com - Investing.com Australia
Agilent Technologies (A) Announces Transition of Chief Legal Off - GuruFocus
How Investors May Respond To Agilent Technologies (A) CRISPR Patent Setback And New BioTek Cytation 9 Launch - Yahoo Finance
Agilent Technologies announces transition of chief legal officer Bret DiMarco - Investing.com
Agilent (NYSE: A) details Chief Legal Officer transition and advisory role - Stock Titan
TRADE NEWS: Agilent Technologies Ships Newest EMPro Software Release for Analyzing 3-D Electromagnet - Yahoo
Agilent Opens CEC in Mumbai to Strengthen India’s Scientific Ecosystem - Chemical Industry Digest
Louisbourg Investments Inc. Sells 12,946 Shares of Agilent Technologies, Inc. $A - marketbeat.com
Is It Time To Revisit Agilent Technologies (A) After Recent Share Price Weakness - Sahm
Lab chromatographs are getting smarter: what Agilent is quietly changing for US labs - AD HOC NEWS
Agilent Technologies | 4: Statement of changes in beneficial ownership of securities-Officer Henson Meghan - Moomoo
Agilent (NYSE: A) SVP surrenders shares to cover RSU tax bill - Stock Titan
Agilent Technologies Reports Fourth-Quarter 2012 Results - Yahoo
Agilent launches Cytation 9 cell imaging multimode reader By Investing.com - Investing.com South Africa
Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader - BioSpace
Agilent's Local Strategy Cuts Supply Chain Risk, Drives India Growth - Whalesbook
Agilent Technologies “in country, for country” strategy helps mitigate supply disruptions - BusinessLine
Agilent Expands India’s Scientific Ecosystem with New Customer Experience Center in Mumbai - healthcareexecutive.in
Agilent expands India’s scientific ecosystem with new customer experience centre in Mumbai - BioSpectrum India
A Stock Price, Quote & Chart | AGILENT TECHNOLOGIES INC (NYSE:A) - ChartMill
Agilent Technologies, Inc. (A) Stock Forecasts - Yahoo! Finance Canada
Synthego Welcomes Supreme Court Order Finalizing Invalidation of Agilent CRISPR Patents - PR Newswire
Agilent Technologies Announces Cash Dividend of 12 Cents per Share - Yahoo
Agilent (A) Unveils Innovative BioTek Cytation 9 Cell Imaging Re - gurufocus.com
Agilent Technologies Inc Announces the Biotek Cytation 9 Cell Imaging Multimode Reader - MarketScreener
Flow Cytometry Market Is Booming So Rapidly | Agilent Technologies Inc. • Danaher • Enzo Life Sciences Inc - openPR.com
Agilent launches Cytation 9 cell imaging multimode reader - Investing.com
Agilent Technologies, Inc. $A Shares Purchased by Vaughan Nelson Investment Management L.P. - marketbeat.com
Agilent Technologies, Inc. $A Shares Sold by Scharf Investments LLC - marketbeat.com
Agilent Technologies Inc. stock rises Tuesday, still underperforms market - MarketWatch
SNP Genotyping and Analysis Market to See Booming Growth - openPR.com
J. Safra Sarasin Holding AG Sells 39,952 Shares of Agilent Technologies, Inc. $A - marketbeat.com
Dissolution Online Systems Market Is Going to Boom | Agilent Technologies • Merck KGaA • PerkinElmer - openPR.com
Forecast Cut: Whats the beta of Agilent Technologies Inc stockMarket Weekly Review & Expert Verified Movement Alerts - baoquankhu1.vn
Agilent Technologies, Inc.: - marketscreener.com
Finanzdaten der Agilent Technologies Inc-Aktie (A)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
0.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):